Founded in 2019 with headquarters in Montreal, QC, FemTherapeutics Inc. is a medical device company with a mission to personalize pelvic medicine for women. The company has developed a data and intelligence platform that leverages artificial intelligence, cloud software, and 3D printing to produce the world’s first category of patient-specific gynaecological prosthetics. Built to provide non-invasive solutions for pelvic health conditions, FemTherapeutics’ first product is indicated to manage the symptoms of Pelvic Organ Prolapse and Stress Urinary Incontinence.